| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Kidney Failure | |||||
| 2 | More general conditions related to this trial | ||||
| Kidney Diseases | |||||
| Renal Insufficiency | |||||
| Urologic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Aggrenox | |||||
| Clopidogrel | |||||
| 4 | More general drug interventions related to this trial | ||||
| Hematologic Agents | |||||
| Pharmacologic Actions | |||||
| Platelet Aggregation Inhibitors | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| The Cleveland Clinic | |||||
| Boston University | |||||
| Duke University | |||||
| University of Iowa | |||||
| Maine Medical Center | |||||
| University of Texas Southwestern Medical Center | |||||
| University of Alabama at Birmingham | |||||
| Washington University School of Medicine | |||||
| Baystate Medical Center | |||||
| Vanderbilt University | |||||
| CAMC Health System | |||||
| Emory University | |||||
| St. Louis University | |||||
| Tyler Nephrology Associates | |||||
| Vascular Surgery Associates | |||||
|
